| Q47772043 | Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q51773790 | Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q37859679 | Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease |
| Q41682577 | Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study. |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q34614038 | Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study |
| Q42976143 | Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica |
| Q36705720 | Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects? |
| Q33806655 | Low prevalence of obesity in Behçet's disease is associated with high obestatin level. |
| Q33652576 | Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease |
| Q36319729 | Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis |
| Q43275139 | Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. |
| Q37335690 | Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits |
| Q26822038 | Metabolic syndrome in rheumatoid arthritis |
| Q31116097 | Metabolic syndrome in rheumatoid arthritis: case control study |
| Q43173649 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus |
| Q39108736 | Methotrexate enhances 3T3-L1 adipocytes hypertrophy. |
| Q37350896 | Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q37801496 | Obesity in rheumatoid arthritis |
| Q47788785 | Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus. |
| Q38368503 | Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis. |
| Q58134529 | Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters |
| Q34681057 | Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis |
| Q41608422 | Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age. |
| Q38858035 | Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases |
| Q37296432 | Prevalence of the metabolic syndrome in rheumatoid arthritis |
| Q35185494 | Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and |
| Q24630655 | Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q47208803 | The association between metabolic syndrome and its components with systemic lupus erythematosus: a comprehensive systematic review and meta-analysis of observational studies. |
| Q37206876 | The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus |
| Q28585701 | The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin |
| Q36132235 | The relationship of metabolic syndrome with disease activity and the functional status in patients with rheumatoid arthritis |
| Q38608906 | The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years? |
| Q35036116 | The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies |
| Q51299339 | The role of methotrexate and low-dose prednisolone on adiponectine levels and insulin resistance in patients with rheumatoid arthritis naïve to disease-modifying antirheumatic drugs. |